| Value | ₹0.07 Cr |
|---|
BSE filing, NSE: DECNGOLD. Summary written from the filing by ALFA Finder's alert engine.
Deccan Gold Mines Ltd: key numbers
- Share price
- ₹171.90
- Market cap
- ₹3,386 Cr
- Revenue (annual)
- ₹14.20 Cr
- Net profit (annual)
- ₹-52.60 Cr
- P/E (TTM)
- -98.1×Sector 16.9×
- Promoter holding
- 20.30%-0.23% QoQ
- FII holding
- 2.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Deccan Gold Mines Ltd
All →Deccan Gold Mines Business Update
Deccan Gold reports maiden drilling at Spain's Logrosan project intersected economic tungsten-tin mineralisation in all eight holes. Preliminary model suggests over 2,000 tonnes of WO3 potential.
Deccan Gold Mines Other Announcement
Deccan Gold Mines Ltd has filed its quarterly shareholding pattern as mandated under Regulation 31 of SEBI LODR for the period ended September 30, 2026.
Deccan Gold Mines Other Announcement
Director Hanuma Prasad Modali sold 8.5 lakh equity shares of Deccan Gold Mines Ltd via an off-market transaction valued at approximately Rs.19.12 Crore.
- Value
- ₹19.12 Cr
Deccan Gold Mines Capital Structure Change
Deccan Gold Mines Limited has allotted 34,000 equity shares under its ESOP scheme. The allotment increases the company's paid-up share capital.
Deccan Gold Mines Legal & Regulatory
Deccan Gold provided an update on Supreme Court proceedings regarding the Ganajur Mining Lease, noting its subsidiary will have an opportunity to present its case.
Deccan Gold Mines Annual General Meeting
Deccan Gold Mines held its 42nd AGM, transacting business including financial statement adoption, director re-appointments, and material related party transaction approvals.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date